MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

151.20
+7.20
+5.00%
After Hours: 151.20 0 0.00% 16:00 04/08 EDT
OPEN
145.45
PREV CLOSE
144.00
HIGH
151.96
LOW
144.09
VOLUME
273.52K
TURNOVER
--
52 WEEK HIGH
178.99
52 WEEK LOW
104.28
MARKET CAP
8.11B
P/E (TTM)
21.96
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ICLR stock price target is 166.93 with a high estimate of 193.00 and a low estimate of 131.00.

EPS

ICLR News

More
  • ICON Signs New Service Agreement With Pfizer
  • Business Wire · 5d ago
  • 6 Health Care Companies Boosting Book Value
  • GuruFocus.com · 6d ago
  • Wells Fargo Maintains Equal-Weight on Icon, Lowers Price Target to $140
  • Benzinga · 03/30 16:13
  • Hedge Funds Were Selling ICON Public Limited Company (ICLR) Before The Coronavirus
  • Insider Monkey · 03/23 13:56

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About ICLR

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
More

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.